High glucose and renin release: The role of succinate and GPR91

Kidney International

Volumn 78, Issue 12, 2010, Pages 1214-1217

  Peti Peterdi, János ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

diabetic nephropathy; renin angiotensin system

Indexed keywords

CELL SURFACE RECEPTOR; CELL SURFACE RECEPTOR GPR 91; GLUCOSE; MITOGEN ACTIVATED PROTEIN KINASE; RENIN; SUCCINIC ACID; TRICARBOXYLIC ACID; UNCLASSIFIED DRUG;

CELL STRESS; CELLULAR STRESS RESPONSE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; ENZYME ACTIVATION; HUMAN; HYPERGLYCEMIA; JUXTAGLOMERULAR APPARATUS; KIDNEY COLLECTING TUBULE; KIDNEY FIBROSIS; MACULA DENSA; NEPHRON; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RECEPTOR INTRINSIC ACTIVITY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENIN RELEASE; SHORT SURVEY; SIGNAL TRANSDUCTION; TISSUE INJURY; TISSUE METABOLISM;

EID: 78649662102     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2010.333     Document Type: Short Survey

References (50)

1. Ritz E, Dikow R. Hypertension and antihypertensive treatment of diabetic nephropathy. Nat Clin Pract Nephrol 2006; 2: 562-567.
2. Kanwar YS, Wada J, Sun L et al. Diabetic nephropathy: mechanisms of renal disease progression. Exp Biol Med (Maywood) 2008; 233: 4-11.
3. Qian Y, Feldman E, Pennathur S et al. From fibrosis to sclerosis: mechanisms of glomerulosclerosis in diabetic nephropathy. Diabetes 2008; 57: 1439-1445.
4. Ziyadeh FN. Mediators of diabetic renal disease: the case for TGF-beta as the major mediator. J Am Soc Nephrol 2004; 15: S55-S57.
5. Sanchez AP, Sharma K. Transcription factors in the pathogenesis of diabetic nephropathy. Expert Rev Mol Med 2009; 11: e13.
6. Brenner BM, Cooper ME, de Zeeuw D et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001; 345: 861-869.
7. Gurley SB, Coffman TM. The renin-angiotensin system and diabetic nephropathy. Semin Nephrol 2007; 27: 144-152.
8. Anderson S, Komers R. Inhibition of the renin-angiotensin system: is more better? Kidney Int 2009; 75: 12-14.
9. Thomson SC, Deng A, Bao D et al. Ornithine decarboxylase, kidney size, and the tubular hypothesis of glomerular hyperfiltration in experimental diabetes. J Clin Invest 2001; 107: 217-224.
10. Faulhaber-Walter R, Chen L, Oppermann M et al. Lack of A1 adenosine receptors augments diabetic hyperfiltration and glomerular injury. J Am Soc Nephrol 2008; 19: 722-730.
11. Sällström J, Carlsson PO, Fredholm BB et al. Diabetes-induced hyperfiltration in adenosine A(1)-receptor deficient mice lacking the tubuloglomerular feedback mechanism. Acta Physiol (Oxf) 2007; 190: 253-259.
12. He W, Miao FJ, Lin DC et al. Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors. Nature 2004; 429: 188-193.
13. Toma I, Kang JJ, Sipos A et al. Succinate receptor GPR91 provides a direct link between high glucose levels and renin release in murine and rabbit kidney. J Clin Invest 2008; 118: 2526-2534.
14. Vargas SL, Toma I, Kang JJ et al. Activation of the succinate receptor GPR91 in macula densa cells causes renin release. J Am Soc Nephrol 2009; 20: 1002-1011.
15. Peti-Peterdi J, Kang JJ, Toma I. Activation of the renal renin-angiotensin system in diabetes-new concepts. Nephrol Dial Transplant 2008; 23: 3047-3049.
16. Hebert SC. Physiology: orphan detectors of metabolism. Nature 2004; 429: 143-145.
17. Sadagopan N, Li W, Roberds SL et al. Circulating succinate is elevated in rodent models of hypertension and metabolic disease. Am J Hypertens 2007; 20: 1209-1215.
18. Fedotcheva NI, Sokolov AP, Kondrashova MN. Nonenzymatic formation of succinate in mitochondria under oxidative stress. Free Radic Biol Med 2006; 41: 56-64.
19. Selak MA, Armour SM, MacKenzie ED et al. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell 2005; 7: 77-85.
20. Schurek HJ, Jost U, Baumgartl H et al. Evidence for a preglomerular oxygen diffusion shunt in rat renal cortex. Am J Physiol 1990; 259: F910-F915.
21. Palm F, Teerlink T, Hansell P. Nitric oxide and kidney oxygenation. Curr Opin Nephrol Hypertens 2009; 18: 68-73.
22. Wilcox CS. Oxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension? Am J Physiol Regul Integr Comp Physiol 2005; 289: R913-R935.
23. Krebs HA. Rate control of the tricarboxylic acid cycle. Adv Enzyme Regul 1970; 8: 335-353.
24. Goldberg ND, Passonneau JV, Lowry OH. Effects of changes in brain metabolism on the levels of citric acid cycle intermediates. J Biol Chem 1966; 241: 3997-4003.
25. Regard JB, Sato IT, Coughlin SR. Anatomical profiling of G proteincoupled receptor expression. Cell 2008; 135: 561-571.
26. Correa PR, Kruglov EA, Thompson M et al. Succinate is a paracrine signal for liver damage. J Hepatol 2007; 47: 262-269.
27. Rubic T, Lametschwandtner G, Jost S et al. Triggering the succinate receptor GPR91 on dendritic cells enhances immunity. Nat Immunol 2008; 9: 1261-1269.
28. Hakak Y, Lehmann-Bruinsma K, Phillips S et al. The role of the GPR91 ligand succinate in hematopoiesis. J Leukoc Biol 2009; 85: 837c843.
29. Sapieha P, Sirinyan M, Hamel D et al. The succinate receptor GPR91 in neurons has a major role in retinal angiogenesis. Nat Med 2008; 14: 1067-1076.
30. Katavetin P, Miyata T, Inagi R et al. High glucose blunts vascular endothelial growth factor response to hypoxia via the oxidative stressregulated hypoxia-inducible factor/hypoxia-responsible element pathway. J Am Soc Nephrol 2006; 17: 1405-1413.
31. Makino H, Miyamoto Y, Sawai K et al. Altered gene expression related to glomerulogenesis and podocyte structure in early diabetic nephropathy of db/db mice and its restoration by pioglitazone. Diabetes 2006; 55: 2747-2756.
32. Nakagawa T. A new mouse model resembling human diabetic nephropathy: uncoupling of VEGF with eNOS as a novel pathogenic mechanism. Clin Nephrol 2009; 71: 103-109.
33. Rosenberger C, Khamaisi M, Abassi Z et al. Adaptation to hypoxia in the diabetic rat kidney. Kidney Int 2008; 73: 34-42.
34. Koivunen P, Hirsilä M, Remes AM et al. Inhibition of hypoxia-inducible factor (HIF) hydroxylases by citric acid cycle intermediates: possible links between cell metabolism and stabilization of HIF. J Biol Chem 2007; 282: 4524-4532.
35. Kang SW, Adler SG, Lapage J et al. p38 MAPK and MAPK kinase 3/6 mRNA and activities are increased in early diabetic glomeruli. Kidney Int 2001; 60: 543-552.
36. Komers R, Lindsley JN, Oyama TT et al. Immunohistochemical and functional correlations of renal cyclooxygenase-2 in experimental diabetes. J Clin Invest 2001; 107: 889-898.
37. Komers R, Lindsley JN, Oyama TT et al. Renal p38 MAP kinase activity in experimental diabetes. Lab Invest 2007; 87: 548-558.
38. Cheng H-F, Wang CJ, Moeckel GW et al. Cyclooxygenase-2 inhibitor blocks expression of mediators of renal injury in a model of diabetes and hypertension. Kidney Int 2002; 62: 929-939.
39. Robben JH, Fenton RA, Vargas SL et al. Localization of the succinate receptor in the distal nephron and its signaling in polarized MDCK cells. Kidney Int 2009; 76: 1258-1267.
40. Rohrwasser A, Morgan T, Dillon HF et al. Elements of a paracrine tubular renin angiotensin system along the entire nephron. Hypertension 1999; 34: 1265-1274.
41. Prieto-Carrasquero MC, Botros FT, Kobori H et al. Collecting duct renin: a major player in angiotensin II-dependent hypertension. J Am Soc Hypertens 2009; 3: 96-104.
42. Kang JJ, Toma I, Sipos A et al. The collecting duct is the major source of prorenin in diabetes. Hypertension 2008; 51: 1597-1604.
43. Kang JJ, Toma I, Sipos A et al. Quantitative imaging of basic functions in renal (patho)physiology. Am J Physiol Renal Physiol 2006; 291: F495-F502.
44. Peti-Peterdi J, Fintha A, Fuson AL et al. Real-time imaging of renin release. Am J Physiol Renal Physiol 2004; 287: F329-F335.
45. Sipos A, Toma I, Kang JJ et al. Advances in renal (patho)physiology using multi-photon microscopy. Kidney Int 2007; 72: 1188-1191.
46. Peti-Peterdi J, Toma I, Sipos A et al. Multi-photon imaging of renal regulatory mechanisms. Physiology (Bethesda) 2009; 24: 88-96.
47. Nguyen G. Increased cyclooxygenase-2, hyperfiltration, glomerulosclerosis, and diabetic nephropathy: put the blame on the (pro)renin receptor? Kidney Int 2006; 70: 618-620.
48. Fiermonte G, Dolce V, Arrigoni R et al. Organization and sequence of the gene for the human mitochondrial dicarboxylate carrier: evolution of the carrier family. Biochem J 1999; 344: 953-960.
49. Markovich D, Murer H. The SLC13 gene family of sodium sulphate/ carboxylate cotransporters. Pflugers Arch 2004; 447: 594-602.
50. Sekine T, Miyazaki H, Endou H. Molecular physiology of renal organic anion transporters. Am J Physiol Renal Physiol 2006; 290: F251-F261.